Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

Similar documents
Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System

Table 1. Coating Parameters

Comparative Evaluation of Enteric Film Coatings Applied in Organic Solvents

Assessment of Low Dose Content Uniformity of Indomethacin in Excipient Blends Using FT-Raman Mapping Spectroscopy

The Effect of Film Coating and Storage Conditions on the Performance of Metformin HCl 500 mg Extended Release Hypromellose Matrices

Opadry Enteric. Application Data. Drug Release from Acrylic-Based Opadry Enteric (94 Series) Coated Tablets INTRODUCTION MATERIALS AND METHODS

Designed and manufactured specifically for pharmaceutical capsule filling

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

STARCH Application Data

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*

SCIENTIFIC DISCUSSION

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement

SCIENTIFIC DISCUSSION. Efavirenz

Extra Strength Echinacea 2500 mg Softgels

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

SUMMARY AND CONCLUSION

SCIENTIFIC DISCUSSION. Darunavir

SCIENTIFIC DISCUSSION

EUDRAGIT L 100 and EUDRAGIT S 100

Fluoxetine Hydrochloride 5.6 mg Oral Chewable Treats (Solid Suspension, 60 x 1 ml Chewable Treats)

Dissolution Shelf Life of Packaged Pharmaceutical Tablet by Prediction and Experiment

The solid choice for Omega-3

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

905 UNIFORMITY OF DOSAGE UNITS

Typical Opadry II coating conditions with a product bed temperature of around o C were found to be suitable

The unlocked synergy of DFE Pharma MCC

Senior Scientist / Principal Scientist. Compounding Manager (Sterile and non-sterile specials) Senior Pharmaceutical Assessor

Savesta Herbals is engaged in manufacturing

Improving performance of high fat containing and soft powders with AEROSIL and SIPERNAT products. Technical Information TI 1405

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Food Solutions. Solutions Designed for Meat Products

Public Assessment Report. Scientific discussion. Pregabalin Orion (pregabalin) SE/H/1440/01-07/DC

Mylan Laboratories Limited F-4 & F-12, Malegaon MIDC, Sinnar Nashik Maharashtra State, India

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

SCIENTIFIC DISCUSSION. AkuriT-3 Tablets*

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Public Assessment Report Scientific discussion. Oxikodon Depot Actavis (oxycodone hydrochloride) SE/H/1313/01-08/DC

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Ingredient Listing Qty. Unit NDC # Supplier

Excipient Considerations for Continuous Manufacturing Implementation

Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride)

Tongkat Ali Extract / Longjack Extract

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Librel. Highly soluble chelates for plant nutrition

MATERIAL SAFETY DATA SHEET

International Atomic Energy Agency. Department of Nuclear Sciences and Applications. IAEA Environment Laboratories

Public Assessment Report Scientific discussion. Oxikodon Actavis (oxycodone hydrochloride) SE/H/1226/01-03/DC

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Abacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575

Received: ; Revised; Accepted: PROCESS VALIDATION OF FORMOTEROL FUMARATE AND BUDESONIDE DRY POWDER INHALATION

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

The right impact on taste and texture CONDITIONING COATING BROCHURE

CHAPTER 6. STABILITY STUDIES

SCIENTIFIC DISCUSSION

The Soft Gel Specialist

Araldite Advanced Materials. Two component toughened methacrylate adhesive system. Structural Adhesives TECHNICAL DATASHEET

Partner with the Global Leader in Drug Delivery Systems

SCIENTIFIC DISCUSSION. Lopinavir and Ritonavir 200 mg/50 mg Tablets * Name of the Finished Pharmaceutical Product:

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

The Nutraceutical Solutions! CERTIFIED ISO

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Challenges in Developing Stable and Efficient Probiotic Formulations

Public Assessment Report Scientific discussion. Echinacea Friggs, effervescent tablet (Echinacea purpurea fresh herb, dried expressed juice (20-28:1))

SCIENTIFIC DISCUSSION

Contract Manufacturing Fluid Bed Technology. Drying. Spray granulation. Coating. Agglomeration. Instantization.

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Public Assessment Report. Scientific discussion. Levofloxacin Bluefish (levofloxacin hemihydrate) SE/H/889/01-02/DC

Care Chemicals & Formulators. Librel BMX. Technical Information. = Registered trademark of BASF group Multi-Micronutrient EDTA Chelate.

Public Assessment Report Scientific discussion. Quetiapin Orion (quetiapine fumarate) SE/H/1115/01-04/DC

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

Your partner in CAPS & CLOSURES. Polyolefins the material of choice for caps & closures.

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

REVISION OF MONOGRAPH ON TABLETS. Tablets

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

Unigel TM Case Study: Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations

Methimazole 5 mg Oral Chewable Treats (Solid Suspension, 60 x 1 ml Treats) FIN F v2. Ingredient Listing Qty. Unit NDC # Supplier

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973

Public Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No:

EUDRAGIT E 100, EUDRAGIT E PO and

Food supplement manufacture

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

Product Safety Assessment VenPure Borohydride Products

FLAVOUR FLOW & ADHESION

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Methacrylate adhesive with good thermal stability. Good adhesion even without particular pretreatment. Mix ratio Parts by weight Parts by volume

In-Vitro Bioequivalence Studies for Oral Solid Dose products using the Morphologi G3-ID

Large scale production

Transcription:

NUTRAFICIENT Application Data Food Supplement Coating Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating OBJECTIVE To stabilize a highly hygroscopic herbal extract in a solid dosage form using a drug layering process followed by a moisture barrier film coating. INTRODUCTION The majority of modern herbal extracts are prepared by an alcohol/water extraction method which tends to give them a hygroscopic nature. This can make it difficult for the extract to be processed into a solid dosage form and stabilized under normal storage conditions. This project evaluated the use of a drug layering process and moisture barrier film coating to produce stable active beads for filling into hard gelatin capsules. Echinacea purpurea (Purple Coneflower) is used widely in the US and Europe as an herbal medicine for its immunostimulant activity. As a result of the European Traditional Herbal Medicines Directive from 2011, all herbs on the European Market must be licensed and meet strict pharmaceutical standards. The use of this technique may make it easier to meet the new stability requirements. METHODOLOGY Materials Echinacea dry pressed juice EFLA 894 (Flachsmann) Marker compound b-1,2-d-fructofuranosides > 2.4%(m/m) Fumed silica (Aerosil 200, Degussa) MCC beads (Ethispheres 600 (600 mm, NP Pharm) Nutraficient, food supplement coating (112A290001 Clear) Equipment: Niro Aeromatic Strea 1 using the bottom spray set up with a 1mm nozzle Watson Marlow peristaltic pump. Ika RW20.n stirrer. Sartorius 4 digit balance. Orion Research Inc. AF8 Titrator. Olympus SZ Microscope. Olympus C3030 zoom digital camera. Process An aqueous suspension of powdered echinacea purpurea extract and silicon dioxide was sprayed onto nonpareil MCC beads to 67% weight gain in a fluid bed processor using a bottom spray module. Silicon dioxide was added to the formulation to reduce the stickiness of the beads during the layering process. A moisture barrier film coating (Nutraficient 112A29001 Clear) was then applied to a 5% weight gain in the same manner. NUTRAFICIENT - 1 -

Formulation The German Commission E Monograph 1 recommends a dose of 6-9 ml of pressed juice, taken from the aerial parts of the plant. This is equivalent to 320 mg of Echinacea purpurea Pressed Juice Extract (EFLA 894), the formulations used deliver a dose of 6 ml of pressed juice per daily dose. Echnacea purpurea Pellet Cores (600 µ m) Table 1. Echinacea Purpurea Bead Formulation 1Kg Batch Per 500 mg 640.5 g Per 320 mg Capsule* Batch Capsule** 640 g 320 mg 320 g 160 mg 270 g 135 mg 270g 134.752 mg Silicon 40 g 20 mg 20 g 10.016 mg Dioxide Nutraficient 50 g 5 mg 30.5 g 15.232 mg *One capsule per day formulation. ** Two capsules per day formulation. Table 2. 112A290001 Drug Layering Atomizing Air Pressure (bar) 2.5 Inlet Air Temperature (ºC) 60-67 Fluid Delivery (g/min) 2.5 Solids Content (%) 58 Film Coating Atomizing Air Pressure (bar) 2.0 Inlet Air Temperature (ºC) 50 Fluid Delivery (g/min) 3-4 Solids Content (%) 15 Extract Characterization Samples of the extract were placed on a glass petri dish and left at room temperature and humidity. Visual observations were made at time 0, 3 and 6 hours. Water absorption by dried extract samples was also evaluated. Samples of high drug loaded beads were placed in clear PVC containers with plastic cap for visual observations after 18 months of storage at room temperature and humidity. Stability Study Samples (3 g) of extract powder and the high and low dose beads were dried in an oven for 2 hours at 105 C. Smaller samples (0.1g) of each material were then transferred into a clear glass vial (28 ml) and placed on stability for 7 days at 25ºC and 60%RH for a moisture absorption test. The high drug loaded beads were also filled into hard gelatin capsules with a 500 mg capsule fill weight and packed in heat induction sealed HDPE bottles for stability storage. The weight of filled capsules, moisture content of beads by Karl Fischer, and appearance of capsules/beads were determined through the 18 month time point under ICH storage conditions. NUTRAFICIENT - 2 -

RESULTS Extract Characterization Figure 1. Visual Observation of Extract Powder at Room Temperature and Humidity, Approximately 20 C and 40-50%RH Camera Microscope Time 0 3 Hours 6 Hours hours 120 100 Figure 2. Weight Gain of 5g Extract Sample Dried at 90C for 18 hours and then Stored at 40ºC 75%RH for 2 Days Echinacea Extract Powder % Weight Gain 80 60 40 20 0 0 6 24 48 Time (Hours) NUTRAFICIENT - 3 -

Figure 3. High Drug Load Formulations: Free Flowing Beads After 18 Months in PVC Container at Room Temperature & Humidity Nutraficient Coating Applied to 5% Weight Gain (112A29001 Clear) Figure 4. Percentage Weight Gain (Equilibrium Moisture Content) 2 After Dried Samples Stored at 25 C and 60%RH for 7 Days 35 % Weight Gain 30 25 20 15 10 5 0 Echinacea Powder High Drug Loading 112A290001 Low Drug Loading 112A290001 The equilibrium moisture content (EMC) was highest for the echinacea powder. EMC increased with increasing loading of echinacea onto the beads. Table 3. Karl Fischer Results for Echinacea Bead Capsules Packed in HDPE Bottles 112A290001 Initial 112A290001 3M 25ºC/60%RH 5.10 +/- 0.99 30ºC/65%RH 4.89 +/- 0.12 6.64 +/- 0.58 40ºC/75%RH 8.21 +/- 1.02 Average weight gain for 3M stability samples of encapsulated beads in HDPE bottles was less than 1% at all ICH conditions. DISCUSSION Coated Echinacea purpurea beads were produced successfully, and they were protected from moisture absorption by the moisture barrier film coatings. After 18 months storage in PVC containers at room NUTRAFICIENT - 4 -

temperature and humidity, the beads coated with either coating system were still free flowing. In contrast, the unprocessed powdered extract liquefied after 3 hours when exposed to the same condition in a glass Petri dish. The EMC of the extract powder is 32% at 25 C/60%RH, while the coated high drug-loaded beads have an EMC of 24%. The low drug-loading beads have an EMC of 17.5% for the 112A290001coating. According to the classification system proposed by Callahan 3, the extract powder is in Class VI, Very Hygroscopic while the coated beads fall into a lower category Class III, Moderately Hygroscopic. The classification further confirms the significant difference in hygroscopicity characteristic between the powder extract and the film coated beads as well as the bead-in-capsule dosage forms. CONCLUSIONS A stable, solid form of echinacea purpurea beads was prepared by layering an aqueous extract onto nonpareil beads followed by an application of a moisture barrier film coating of Nutraficient. The physical stability of the beads was proven satisfactory for up to 18 months as compared to a few hours of the unprocessed powdered extract. Similar stability was also obtained with beads-in-capsules. This technology can also be applied to other hygroscopic herbal extracts. REFERENCES 1. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. The American Botanical Council. Blumenthal M. et al. 2. Visalakshi, N.A. ; Mariappan, T.T ; Bhutani, H. Pharm Dev and Tech 10. 498-497 2005. 3. Callahan, J.C. et al Drug Dev Ind Pharm. 8. 355-369 1982. The information contained herein, to the best of Colorcon, Inc. s knowledge is true and accurate. Any recommendations or suggestions of Colorcon, Inc. with regard to the products provided by Colorcon, Inc. are made without warranty, either implied or expressed, because of the variations in methods, conditions and equipment which may be used in commercially processing the products, and no such warranties are made for the suitability of the products for any applications that you may have disclosed. Colorcon, Inc. shall not be liable for loss of profit or for incidental, special or consequential loss or damages. Colorcon, Inc. makes no warranty, either expressed or implied, that the use of the products provided by Colorcon, Inc., will not infringe any trademark, trade name, copyright, patent or other rights held by any third person or entity when used in the customer s application. For more information, contact your Colorcon representative or call: North America Europe/Middle East/Africa Asia Pacific Latin America +1-215-699-7733 +44-(0)-1322-293000 +65-6438-0318 +54-11-4552-1565 NUTRAFICIENT - 5 - You can also visit our website at www.colorcon.com Colorcon, 2010. The information contained in this document is proprietary to Colorcon and may not be used or disseminated inappropriately. All trademarks, except where noted, are property of BPSI Holdings, LLC. ads_nutraficient_prot_proc_v2_05_2010